Back

HFWM: Complex effects of the myosin activator omecamtiv mecarbil on cardiac contractility

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Basic Science: Drug therapy, other Drug therapy, other HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Finn Olav Levy

University of Oslo, Oslo (Norway)

3 More presentations in this session

Presentation thumbnail
Comparative bioenergetic effects of levosimendan and omecamtiv mecarbil in guinea-pig cardiac myocytes
Miss D. Puetz (Homburg, DE)
Abstract Slides
Presentation thumbnail
Circulating blood levels of growth differentiation factor 11 are decreased in dogs with heart failure and restored after long-term therapy with elamipretide (Bendavia, MTP-131)
Professor H. Sabbah (Detroit, US)
Abstract Slides
Presentation thumbnail
Trimetazidine effects on the quality of life of women with chronic heart failure
Doctor N. Koriagina (Perm, RU)

Access the full session

Session thumbnail
Poster Session 3 - Basic Science: Drug therapy, other

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources